SAPHO syndrome treated with pamidronate: An open-label study of 10 patients

Rheumatology

Volumn 43, Issue 5, 2004, Pages 658-661

  Amital, H ^b   Applbaum, Y H ^a   Aamar, S ^b   Daniel, N ^a   Rubinow, A ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b Rheumatology Unit   (Israel)

Author keywords

Bisphosphonates; Osteitis; Pamidronate; SAPHO; Spondyloarthropathy

Indexed keywords

CALCITONIN; COLCHICINE; CORTICOSTEROID; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; SALAZOSULFAPYRIDINE; TECHNETIUM 99M;

ACNE; ADULT; AGED; ARTHRITIS; ARTICLE; BONE PAIN; BONE SCINTISCANNING; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; HUMAN; HYPEROSTOSIS; JEW; MALE; OPEN STUDY; OSTEITIS; PRIORITY JOURNAL; PSORIASIS VULGARIS; PUSTULOSIS; REMISSION; SAPHO SYNDROME; STERNOCLAVICULAR JOINT; STERNOCOSTAL JOINT; TREATMENT FAILURE;

ACQUIRED HYPEROSTOSIS SYNDROME; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; DIPHOSPHONATES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 2442417681     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh149     Document Type: Article

References (22)

1. Hayem G, Bouchaud-Chabot A, Benali K et al. SAPHO syndrome: a long-term follow-up study of 120 cases. Semin Arthritis Rheum 1999;29:159-71.
2. Watts RA, Crisp AJ, Hazleman BL, Daunt SO, Jenner JR. Arthro-osteitis - a clinical spectrum. Br J Rheumatol 1993;32:403-7.
3. Bognar M, Blake W, Agudelo C. Chronic recurrent multifocal osteomyelitis associated with Crohn's disease. Am J Med Sci 1998; 315:133-5.
4. Maugars Y, Berthelot JM, Ducloux JM, Prost A. SAPHO syndrome: a follow-up study of 19 cases with special emphasis on enthesis involvement. J Rheumatol 1995;22:2135-41.
5. Maksymowych WP, Jhangri GS, Fitzgerald AA et al. A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis. Arthritis Rheum 2002;46:766-73.
6. Pennanen N, Lapinjoki S, Urtti A, Monkkonen J. Effect of liposomal and free bisphosphonates on the IL-1β, IL-6, and TNFα secretion from RAW264 cells in vitro. Pharm. Res 1995; 12:916-22.
7. De Vries E, Van der Weij JP, Van der Veen CJP, et al. In vitro effect of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonic acid (APD) on the function of mononuclear phagocytes in lymphocyte proliferation. Immunology 1982;47:157-63.
8. Marshall H, Bromilow J, Thomas AL, Arden NK. Pamidronate: a novel treatment for the SAPHO syndrome? Rheumatology 2002;41:231-3.
9. Guignard S, Job-Deslandre C, Sayag-Boukris V, Kahan A. Pamidronate treatment in SAPHO syndrome. Joint Bone Spine 2002;69:392-6.
10. Benhamou CL, Enjolras O, Delrieu F, Prier A, Camus JP, Amor B. Pseudoseptic arthritis and bacterid of Andrews. Rev Rhum Mal Osteoartic 1984;51:229-31.
11. Van Doornum S, Barraclough D, McColl G, Wicks I. SAPHO: rare or just not recognized? Semin Arthritis Rheum 2000;30:70-7.
12. Hukuda S, Minami M, Saito T, et al. Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis Society. J Rheumatol 2001;28:554-9.
13. Berenson JR. Advances in the biology and treatment of myeloma bone disease. Semin Oncol 2002;29(6 Suppl. 17):11-6.
14. Siris ES. Goals of treatment for Paget's disease of bone. J Bone Miner Res 1999; 14(Suppl. 2):49-52.
15. Berenson JR. Treatment of hypercalcemia of malignancy with bisphosphonates. Semin Oncol 2002;29(6 Suppl. 21):12-18.
16. Green JR. Antitumor effects of bisphosphonates. Cancer 2003;1:97 (3 Suppl.):840-7.
17. Russel RGG, Rogers MJ. Bisphosphonates: from the laboratory to the clinic and back again. Bone 1999;25:97-106.
18. Garske LA, Bell SC. Pamidronate results in symptom control of hypertrophic pulmonary osteoarthropathy in cystic fibrosis. Chest 2002;121:1363-6.
19. Kubalek I, Fain O, Paries J, Kettaneh A, Thomas M. Treatment of reflex sympathetic dystrophy with pamidronate: 29 cases. Rheumatology 2001;40:1394-7.
20. Selby PL, Young MJ, Boulton AJ. Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabet Med 1994;11:28-31.
21. Sayag-Boukris V, Loussadi I, Cormier C, Laroche F, Menkes CJ, Kahan A. Efficacy of pamidronate in the treatment of SAPHO syndrome [abstract]. Arthritis Rheum 1998;41(Suppl. 9):S114.
22. Courtney PA, Hosking DJ, Fairbairn KJ, Deighton CM. Treatment of SAPHO with pamidronate. Rheumatology 2002;41:1196-8.